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Abstract   49 
Hepatic fat-specific protein 27 (Cidec/Fsp27) mRNA levels have been 50 
associated with hepatic lipid droplet extent under certain circumstances. To address its 51 
hepatic expression under different dietary conditions and in both sexes, Apoe-deficient 52 
mice were subjected to different experimental conditions for 11 weeks to test the 53 
influence of cholesterol, Western diet, squalene, oleanolic acid, sex and surgical 54 
castration on Cidec/Fsp27 mRNA expression. Dietary cholesterol increased hepatic 55 
Cidec/Fsp27β expression, an effect that was suppressed when cholesterol was combined 56 
with saturated fat as represented by Western-diet feeding. Using the latter diet, oleanolic 57 
acid or squalene did not modify its expression. Females showed lower levels of hepatic 58 
Cidec/Fsp27β expression than males when they were fed Western diets, a result that 59 
was translated into lesser amount of CIDEC/FSP27 protein in lipid droplets and 60 
microsomes. This was also confirmed in Ldlr-deficient mice. Incubation with estradiol 61 
resulted in decreased Cidec/Fsp27β expression in AML12 cells. While male surgical 62 
castration did not modify the expression, ovariectomized females did show increased 63 
levels compared to control females. Females also showed increased expression of 64 
Pgc1a, suppressed by ovariectomy, and the values were significantly and inversely 65 
associated with those of Cidec/Fsp27β. When Pgc1a-deficient mice were used, the sex-66 
differences on Cidec/Fsp27β expression disappeared. Therefore, hepatic Cidec/Fsp27β 67 
expression has a complex regulation influenced by diet and sex hormonal milieu. The 68 
mRNA sex differences are controlled by Pgc1a. 69 
Keywords:  70 
Lipids/liver, lipid droplets, animal models, gene expression, non-alcoholic fatty liver 71 
disease, Cidec/Fsp27, Pgc1a, apolipoprotein E deficient mice, high-fat diet, sex. 72 




Fat-specific protein 27 (FSP27) gene encodes a protein of 27 kDa with 238 75 
amino acids, belonging to the cell-death-inducing DNA fragmentation effector (CIDE) 76 
family, composed of CIDEA, CIDEB, and CIDEC/CIDE-3/FSP27, all of which contain 77 
a conserved CIDE N-domain and a unique C-terminal domain. Cidec/Fsp27 is 78 
expressed at high levels in white adipose tissue (26). By alternative splicing in HepG2, 79 
CIDE-3 gene displays two transcripts, CIDE-3 and CIDE-3alpha. While CIDE-3 80 
comprises a full-length open reading frame, CIDE-3alpha encodes a truncated protein 81 
(29). In the liver, a third transcript, FSP27β, which contains 10 additional amino acids at 82 
the N-terminus of the original protein and is activated through the liver-enriched 83 
transcription factor cyclic-AMP-responsive-element-binding protein H (CREBH) but 84 
not by peroxisome proliferator-activated receptor gamma, has been described (11, 64). 85 
In this organ, CIDEC/CIDE-3/FSP27 contributes to triglyceride accumulation both in 86 
humans and pigs (28) and to the regulation of lipidation and maturation of very low-87 
density lipoproteins (63). It is localized to lipid droplets (LD) and endoplasmic 88 
reticulum (56). The latter participates in the regulation of LD formation, expansion, and 89 
morphology under lipid-deficient conditions (25). To promote the formation of a 90 
unilocular droplet, the formation a ternary complex of AS160, the GTPase activating 91 
protein for RAB8a, FSP27 and RAB8a is required (60).  92 
Fsp27-deficient mice show increased energy expenditure and lower levels of 93 
plasma triglycerides and free fatty acids (39). Only when they are crossed with leptin-94 
deficient mice or BATless mice, or are fed them a high-fat diet, hepatic steatosis and 95 
insulin resistance are observed. Therefore, Fsp27 deficiency requires further implication 96 
of genes to display hepatic insulin resistance (58, 69). In contrast, mice with adipocyte-97 
specific disruption of the Fsp27 gene upon high-fat diet feeding are resistant to weight 98 
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gain and fat-storing. This results in a lipid overflow from adipose tissue that generates 99 
hepatosteatosis, dyslipidemia, and systemic insulin resistance pointing out a role for this 100 
adipocyte protein to prevent lipodystrophies (57). An increased expression of Cidec has 101 
been found in a number of experimental or pathological conditions, such as in 102 
endoplasmic reticulum stress (24), spontaneous mouse insulin resistance (52) and 103 
hepatocellular carcinoma cells (37). Similar effects have been described in liver 104 
steatosis and in obese humans (13), being the latter increase reduced by weight loss 105 
(16). A homozygous human mutation of CIDEC has been reported to induce 106 
lipodystrophy and insulin-resistant diabetes (40, 49). Reduced expression of hepatic 107 
Fsp27 abolished fasting-induced liver steatosis (23) and the former condition in 108 
combination with a PPARalpha agonist was also found to reduce hepatic steatosis (45) 109 
and even atherosclerosis (46) in Ldlr-deficient mice, a model of atherosclerosis and 110 
hepatosteatosis (50).  111 
The expression of CIDEC is controlled at both transcriptional and 112 
posttranslational levels (5, 13). Different molecules seem to be involved in its 113 
expression, such as CD44 (17) or osteopontin, whose absences decrease its levels (22), 114 
while leptin absence displays the opposite (35). Ceramide (27) and TNF-alpha reduced 115 
its expression while insulin upregulated it. In the latter response, the activity of 116 
phosphatidylinositol 3-kinase was involved (21), so was the phosphatase and tensin 117 
homologue, an enzyme involved in degradation of phosphorylated phosphatidylinositol 118 
(51). Final effectors of these signaling pathways seem to be nuclear receptors such as 119 
TAK1/TR4/NR2C2, RORalpha and PPARalpha, nuclear proteins (CAAT-enhancer-120 
binding proteins), LXRα and SREBP-1c (3, 7, 8, 18, 19, 23). Peroxisome proliferator-121 
activated receptor gamma2 (PPARgamma2) also plays a role (34). Posttranslational 122 
regulation of FSP27 involves stability through the proteasomal ubiquitin-dependent 123 
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protein catabolic process (68), glycosylation (66) and acetylation (44). 124 
A complex physiological regulation of CIDEC seems to exist, in which fasting 125 
and diet composition play important roles. In this regard, during the initial stages of 126 
fasting, Fsp27 expression has been found dramatically increased by involvement of the 127 
PKA-CREB-CRTC2 signaling pathway (59). The fasting effect was not present in 128 
PPARalpha-deficient mice (67). However, after a long period of fasting, a decrease in 129 
Fsp27 expression was observed (59). Despite the observed hepatic steatosis after a 130 
choline-deficient diet, no changes were observed for Fsp27 (67).  Nevertheless, a 131 
marked induction of its expression was found in the high-fat- or methionine- and 132 
choline-deficient diet-induced fatty liver, but not in alcohol-induced fatty liver. The 133 
induction of Fsp27 mRNA was independent of peroxisome proliferator-activated 134 
receptor gamma (PPARgamma) levels and completely absent in the liver from 135 
PPARgamma-deficient mice (2). In less extreme dietary conditions, it has been reported 136 
that a high fat diet increased Fsp27 expression through activation of PPARgamma (41). 137 
In vitro, a high supply of fatty acids stimulated hepatic expression (25). Using Apoe-138 
deficient mice as a model of spontaneous hepatosteatosis, nature of fatty acids was 139 
important to increase its expression in these mice fed a Western-type diet enriched with 140 
linoleic acid isomers since only those mice receiving trans-10, cis-12-conjugated 141 
linoleic acid showed this effect. Furthermore, consuming olive oil-enriched diet reduced 142 
Fsp27 expression (15). In addition, only one study has addressed the influence of sex on 143 
its expression in young mice (12). Growth hormone has also found to regulate this 144 
protein (53, 54). Therefore, influence of sex may be different in adult mice. Based on 145 
these facts, it was hypothesized that Fsp27 hepatic regulation might be the result of 146 
complex interactions of dietary components and sex. To this end, the present work was 147 
undertaken to characterize the influence of different dietary conditions and sex on 148 
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Fsp27 gene expression in adult liver of several animal models. 149 
  150 
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Charles River (Charles River Laboratories, Barcelona, Spain) was the source of 153 
Apoe-deficient mice on the C57BL/6J genetic background. Dr. Nobuyo Maeda 154 
(University of North Carolina at Chapel Hill, NC, USA) generously provided these 155 
mice on the C57BL/6JxOla129 genetic background. Ldlr-deficient mice on the 156 
C57BL/6J.SJL genetic background were obtained from Dr. Vicente Andrés from CNIC, 157 
(Madrid, Spain). C57BL/6J wild-type and Pgc1a-deficient mice were part of a colony 158 
established at the IIB animal facility (Madrid) and originally derived from mice 159 
provided by Dr. Bruce Spiegelman (DFCI, Boston, USA). Wistar rats were obtained 160 
from Charles River (Charles River Laboratories, Barcelona, Spain). 161 
For all experiments, two-month-old mice were used. Blood samples were taken 162 
(after four-hour fasting) from the facial vein to determine plasma cholesterol and 163 
accordingly establish groups with similar initial values. Animals, housed in sterile filter-164 
top cages, were maintained under a 12-h light/12-h dark cycle at the CIBA, Universidad 165 
de Zaragoza. Pgc1a-deficient mice were maintained at Autónoma Universidad de 166 
Madrid. Wistar rats were maintained at Universidad de Córdoba. Animals were handled 167 
and killed observing guidelines (Directive 2010/63/UE) from the European Union for 168 
care and use of laboratory animals in research. All had ad libitum access to food and 169 
water and study protocols were approved by the Ethics Committees for Animal 170 
Research of the Universities of Zaragoza, Madrid and Córdoba. After the diet 171 
intervention, and four-hour fast, the animals were killed by suffocation with CO2. The 172 
livers were removed, weighed, frozen in liquid nitrogen, and stored at − 80 °C until 173 
analysis. 174 
Experimental design 175 
Table 1 provides detailed information of all experimental designs regarding 176 
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characteristics of animals, type of diets, number of animals and length of intervention. 177 
Since C57BL/6J mice do not express hepatic Cidec/Fsp27 (35, 59), we decided to use 178 
Apoe-deficient mice which showed hepatic expression of this gene influenced by some 179 
dietary components (15). Using this model, we tested the effects on Cidec/Fsp27 180 
expression of dietary cholesterol, Western diet and sex. On Western diet, the influence 181 
of two modifiers of lipid droplet surface, oleanolic acid (10) and squalene (14) were 182 
tested. Likewise, this diet was used to analyze sex differences and its inhibition by 183 
surgical castration. A confirmation of the effects of ovariectomy on Cidec/Fsp27 184 
expression was carried out in female Wistar rats fed a Western diet. Since sex 185 
differences emerged on Western diet, this was also tested in another model of hepatic 186 
steatosis, Ldlr-deficient mice on C57BL/6J genetic background. All previous 187 
experiments were suggestive of an involvement of PGC1a and to confirm such issue, 188 
Pgc1-deficient mice on C57BL/6J genetic background fed a purified Western diet were 189 
used to analyze the sex differences on hepatic Cidec/Fsp27 expression. Detailed 190 
compositions of purified diets are shown in supplementary Table 1.  191 
 192 
Isolation and quantification of hepatic RNA 193 
 RNA was isolated using Tri-reagent (Ambion, Austin, TX, USA). Contaminant 194 
DNA was removed using the DNA removal kit from Ambion. Absorbance at A260/280 195 
served to quantify RNA concentrations and the ratio 28S/ 18S ribosomal RNAs used to 196 
estimate their quality.  Changes in mRNA expression were determined by RT-qPCR. 197 
cDNA synthesis was carried out using the First Strand synthesis kit (Thermo Scientific, 198 
Madrid, Spain). The Sybr Green PCR Master Mix (Applied Biosystems, Foster City, 199 
CA) was used to analyze gene expression by qPCR. Specific primers, designed and 200 
checked as previously described (33) were purchased from Applied Biosystems. 201 
Sequences are shown in supplementary Table 2. RT-qPCR reactions were performed on 202 
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a Step One Real Time PCR System (Applied Biosystems) following the standard 203 
procedure and using equal amounts of DNA-free RNA from each animal. The relative 204 
amount of all mRNAs was calculated using the comparative 2-ΔΔCq method and 205 
Cyclophilin B (Pipb) mRNA expression as the reference gene. 206 
Liver histology analyses 207 
Aliquots of liver, stored in neutral formaldehyde, were used and processed as 208 
described (14). 209 
Hepatic homogenate and lipid extraction 210 
A piece of liver was homogenized in homogenization buffer (phosphate buffered 211 
solution with protease inhibitor cocktail (Roche, Mannheim, Germany) and used to 212 
assay protein concentration by the BioRad dye binding assay (BioRad, Madrid, Spain). 213 
Extracted lipids according to Folch’s method (9) were evaporated under N2 stream and 214 
dissolved in 100 µL of isopropanol. Infinity kits (Thermo Scientific) were used to 215 
measure total cholesterol and triglycerides. 216 
Preparation of microsomal fractions 217 
This fraction was prepared according to Osada et al. (43). Basically, 600 mg of 218 
pooled hepatic tissue of each group were homogenized in 2 mL of  0.25 M sucrose 219 
containing the Roche protease inhibitor cocktail at 4ºC and centrifuged at 280g for 5 220 
min. Supernatants were centrifuged at 1500g for 10 min followed by another 221 
centrifugation at 19000g for 10 min to collect the supernatants containing cytosolic and 222 
microsomal proteins. After a centrifugation at 100000g for 60 min, the obtained pellets 223 
containing the microsomal fractions were resuspended in PBS containing 0.2% Triton 224 
X-100 and 10% glycerol and centrifuged at 12000 rpm 10 min in order to remove 225 




Preparation of lipid droplets 228 
They were prepared following the protocol of Ontko et al. (42). Briefly, pooled 229 
hepatic tissue (600 mg) of each group were homogenized in 3 ml of 65% sucrose 230 
solution with protease inhibitor cocktail (Roche, Mannheim, Germany) at 4ºC. 231 
Discontinuous sucrose gradients were prepared as follows: 3 ml of liver homogenates in 232 
65% sucrose were pipetted at the bottom of the centrifuge tubes kept in an ice bath. 233 
Then 2 ml of 60% sucrose solution were slowly added, followed by 2 ml of 52% 234 
sucrose, 2 ml of 44% sucrose and 2 ml of distilled water. The tubes with the gradients 235 
were centrifuged at 25000g for 30 min at 4ºC and the bands containing the different 236 
lipid droplets were collected. They were mixed with 3 volumes of acetone and kept at -237 
80ºC for 10 min and then at -20ºC overnight. The tubes were centrifuged at 15000g for 238 
15 min at 4ºC. The pellets were washed three times, firstly with acetone: diethyl ether 239 
1:1 and then twice with diethyl ether. Dry pellets were resuspended in PBS containing 240 
0.2% Triton X-100 and 10% glycerol and centrifuged at 12000 rpm 10 min in order to 241 
remove insoluble proteins.  Protein concentrations were determined by BioRad dye 242 
binding assay. 243 
Western blot 244 
20 μg of protein were loaded onto a 10% SDS-polyacrylamide gel and 245 
electrophoresed for 120 min at 90V in a Bio-Rad Miniprotean cell (Hercules, CA). 246 
Proteins were transferred to PVDF membranes (GE Healthcare, Madrid, Spain). 247 
Membranes were blocked with PBS buffer containing 5% BSA for 1 h at room 248 
temperature. The primary antibodies, diluted in PBS buffer containing 2.5% BSA and 249 
1% Tween 20, were added and the membranes were incubated 2 h at room temperature 250 
and then overnight at 4ºC. FSP27 protein expression was evidenced by using a rabbit 251 
polyclonal antibody (NB100-430 diluted 1/1,000, Novus Biologicals, Centennial, 252 
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Colorado, USA). Equal loadings were confirmed by using a goat polyclonal anti-HSC70 253 
(TA302666 diluted 1/500, OriGene, Rockville, MD, USA). Membranes were washed 254 
with PBS buffer containing 0.1% Tween 20. Conjugated goat anti-rabbit IgG (H&L) 255 
DyLight 800 secondary antibody (SA5-35571, diluted 1/15,000, Thermo-scientific, 256 
Waltham, MA, USA) for FSP27 detection and a donkey anti-goat IRDye 680RD (926-257 
68074, diluted 1/5,000, LI-COR Biosciences, Lincoln, NE, USA) for HSC70 detection 258 
were used and incubated for 1 h at room temperature in PBS buffer containing 2.5% 259 
BSA and 1% Tween 20. Images were captured using an Odyssey® Clx (LI-COR).  260 
AML12 cell culture 261 
The murine hepatocyte cell line was grown in a humidified atmosphere of 5% 262 
CO2 at 37ºC in Dulbecco's modified Eagle's minimum essential medium (DMEM) 263 
(ThermoFisher Scientific,  Waltham, MA, USA): F12-Ham’s medium (GE Healthcare 264 
Life Science, South Logan, Utah) in 1:1 ratio supplemented with 10% foetal bovine 265 
serum (ThermoFisher Scientific), 1:500 insulin/transferrin/selenium (Corning, Bedford, 266 
MA, USA), 40 ng/ml dexamethasone (Sigma-Aldrich; Merck Millipore, Darmstadt, 267 
Germany) 1% nonessential amino acids (ThermoFisher Scientific), 1% penicillin (1000 268 
U/ml) (ThermoFisher Scientific), 1% streptomycin (1000 mg/ml) (ThermoFisher 269 
Scientific) and 4 mM L-glutamine (ThermoFisher Scientific) in a 6 multiwell plate (in 270 
triplicate). Medium was changed every two days. After one week of growth, this 271 
medium was removed, and cells were washed twice with phosphate buffered saline 272 
(PBS) prior to the addition of the serum-free media supplemented with 200 µm stearic 273 
acid for 24 hours or 200 µM stearic acid for 24 hours and 50 nM estradiol dissolved in 274 
ethanol for 6 hours. Then, media were removed and cells collected with Tri-reagent 275 
solution (Ambion). RNA isolation and cDNA synthesis were performed as above 276 
described.  277 
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Reporter assays 278 
The genomic region -2042 bp to 0 bp at 5’ side of the starting transcription site 279 
of CIDEC/FSP27β (XM_024453700.1) from human genomic DNA was amplified by 280 
PCR using direct (5’-agaaccagatcttggCAAGTGATCCACCTGCCTCG-3) and reverse 281 
(5’-gatatctgcagaattGAGCAGATAACCCAACTCAGGGC -3’) primers. The 2-kb PCR 282 
product was cloned upstream a secreted Gaussia luciferase (GLUC) reporter gene using 283 
linearized pEZX-GAO1 (Genecopeia Rockville, Maryland, USA) according to In-284 
Fusion® cloning protocol from Takara-Clontech (Cat No 638909, Kusatsu, Shiga, 285 
Japan). Restriction enzymes and DNA sequencing confirmed the resulting plasmid. This 286 
latter was transfected to AML12 cells alone or in combination with a plasmid 287 
containing Pgc1a (MN_008904) under the control of CMV promoter (MC204789, 288 
Origene) using lipofectamine 3000 (ThermoFisher) following manufacturer’ 289 
instructions. Two days after, media were taken and secreted GLUC and alkaline 290 
phosphatase, also present in pEZX-GAO1, activities were evaluated. The ratio of 291 
GLUC/alkaline phosphatase was calculated. 292 
Statistical analysis 293 
The Statistical Package for Social Sciences version 15 (SPSS, Chicago, IL, 294 
USA) or Prism 5 for windows software for Windows (GraphPad, S. Diego, CA, USA) 295 
were used for statistical analyses. Variables, not showing normal distribution (according 296 
to the Shapiro-Wilk’s test), or homology of variance, were analyzed with the Mann-297 
Whitney’s U test. Data are shown as medians and 10-90 percentile range of the values. 298 
Correlations between variables were tested using the Spearman’s correlation test. The 299 
statistical significance was considered when p < 0.05. 300 




Dietary fat and hepatic Cidec/Fsp27β expression in Apoe-deficient mice. 303 
To characterize the dietary regulation of the expression of this gene in mice, the 304 
supplement of dietary cholesterol to male mice was tested. Increased hepatic surface 305 
occupied by lipid droplets as well as hepatic total cholesterol and triglyceride contents 306 
(Fig 1a, b and c) were observed following dietary cholesterol supplementation. The 307 
latter induced a significant increase in the hepatic Cidec/Fsp27β expression as shown in 308 
Fig 1d.  309 
Hepatic cholesterol content was associated with hepatic Cidec/Fsp27β expression (Fig 310 
1e).  311 
In a second study, the influence of a Western diet (WD), containing cholesterol 312 
and palm oil as source of saturated fat, was explored in male Apoe-deficient mice on 313 
C57BL/6J genetic background (Fig 2). Significant increased hepatic areas occupied by 314 
lipid droplets (Fig 2a, b and c) as well as hepatic total cholesterol and triglyceride 315 
contents were also observed in mice on the Western diet. Unexpectedly, a significant 316 
decrease of hepatic Cidec/Fsp27β expression was found (Fig 2d). These expression 317 
changes were inversely associated with hepatic cholesterol (Fig 2e). 318 
To further explore this dissociation between hepatic Cidec/Fsp27β and Western 319 
diet, its expression was tested in two dietary components that had been shown to 320 
influence dietary droplets without altering lipid content (oleanolic acid) or viceversa 321 
(squalene). In the first experiment and as expected, male mice receiving an oleanolic 322 
acid-enriched WD showed  an increase in the hepatic area occupied by lipid droplets 323 
(Supplementary Fig 1a, b and c) without changes in hepatic cholesterol and triglyceride 324 
contents (Supplementary Fig 1c). In these conditions, no significant change was 325 
observed for hepatic Cidec/Fsp27β expression (Supplementary Fig 1d). In the second 326 
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experiment, the effect of a squalene-enriched WD was explored, again in males. No 327 
significant changes were noted for the percentage of hepatic surface occupied by lipid 328 
droplets despite the decreased liver cholesterol and triglyceride contents 329 
(Supplementary Fig 2a, b and c). Nor was there any significant change in the hepatic 330 
Cidec/Fsp27β expression by squalene (Supplementary Fig 2d). Overall, these nutritional 331 
experiments emphasize that hepatic Cidec/Fsp27β expression possesses a fine 332 
nutritional regulation at transcriptional level in Apoe-deficient mice, where cholesterol 333 
increased its levels and saturated fat reverted this finding, being the latter not influenced 334 
by minor dietary components, such as oleanolic acid or squalene, despite the changes in 335 
hepatic lipids. 336 
 337 
Hepatic Cidec/Fsp27β expression is influenced by sex hormones in Apoe-deficient mice 338 
and in vitro.  339 
 The influence of sex on Cidec/Fsp27β expression was explored in Apoe-340 
deficient mice on a chow diet of low fat content. As shown in Supplementary Fig 3, 341 
panels a,b,c, females showed lower surface occupied by lipid droplets despite a 342 
significant increase in hepatic cholesterol content and no changes in triglycerides. In 343 
this experiment, no significant changes were observed in hepatic Cidec/Fsp27β between 344 
sexes. In a second experiment, the differences between sexes were explored when both 345 
groups received a WD. As shown in Fig 3a, b and c, no significant change was observed 346 
in the percentage of liver surface occupied by lipid droplets. However, the levels of 347 
hepatic total cholesterol and triglycerides were significantly lower in females than in 348 
males. In this experimental approach, females showed significantly decreased hepatic 349 
Fsp27β expression (Fig 3d). The latter was significantly associated with hepatic 350 
triglyceride contents (Fig 3e). This mRNA decrease was translated in decreased 351 
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amounts of CIDEC/FSP27 protein in lipid droplets and microsomes (Fig 3f and g). 352 
These data indicate that sex is playing an important role in hepatic Cidec/Fsp27β 353 
expression in the presence of WD and these changes are reflected in a lesser amount of 354 
CIDEC in hepatic lipid droplets of female livers. 355 
 The involvement of hormonal changes on sex-differences was characterized in 356 
Apoe-deficient mice of both sexes that underwent surgical removal of gonads and were 357 
fed a purified Western diet. As shown in Supplementary Fig 4, no significant change in 358 
Cidec/Fsp27β expression was observed in orchiectomized males; nor was there any 359 
significant change in hepatic total cholesterol, or in hepatic triglycerides. However, 360 
there was a significant increase in the liver surface occupied by lipid droplets in 361 
orchiectomized males. In contrast, ovariectomy resulted in significant increases in 362 
hepatic cholesterol, triglycerides, and in the surface occupied by lipid droplets (Fig 4c). 363 
Ovariectomized females showed a significant increase in Cidec/Fsp27β expression 364 
compared to control females (Fig 4d). A positive significant association was also found 365 
between hepatic Cidec/Fsp27β values and those of hepatic triglycerides (Fig 4e). The 366 
increase in mRNA expression was translated into increased contents of CIDEC proteins 367 
in lipid droplets and microsomes (Fig 4f and g). These results indicate that ovarian 368 
hormones are responsible for the decreased hepatic Cidec/Fsp27β expression observed 369 
in females consuming WD. In fact, incubation of stearic-stimulated hepatic AML12 370 
cells with estradiol resulted in a significant decrease in Cidec/Fsp27β expression 371 
(Supplementary Fig 5a).  372 
Pgc1a is involved in hepatic Cidec/Fsp27β expression sex differences in vivo.  373 
PKA and PPAR have been described in the regulation of hepatic Cidec/Fsp27 374 
expression (3, 7, 8, 18, 19, 23). To verify whether or not those agents were involved in 375 
the observed sex-dependent responses, hepatic Prka2 expression was determined and no 376 
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significant changes were observed (data not shown). Regarding PPARgamma, the 377 
hepatic expression of its regulator, Pgc1a, was significantly increased in females 378 
compared to males consuming the Western diet (Fig 5a) and an inverse significant 379 
relationship was found between Cidec/Fsp27β expression and that of Pgc1a in both 380 
sexes (Fig 5b). While orchiectomy had no effect on Pgc1a expression (Fig 5c), 381 
ovariectomy induced a significant decrease in its expression in Apoe-deficient females 382 
(Fig 5d). Likewise, ovariectomized female rats also showed a trend to increase 383 
Cidec/Fsp27β expression (Supplementary Fig 6e) and decreased hepatic Pgc1a 384 
expression (Supplementary Fig 6f). Both effects were even more pronounced in rats 385 
neonatally androgenized by testosterone administration and then ovariectomized. In this 386 
model, hepatic fat, cholesterol and TG contents followed a similar pattern 387 
(Supplementary Fig 6d) and Cidec/Fsp27β expression was associated with hepatic TG 388 
content (data not shown). The sex differences in Cidec/Fsp27β expression were 389 
observed in Ldlr-deficient fed on WD as well (Supplementary Fig 7d). Concomitantly, a 390 
significant increase in Pgc1a expression was observed in these female mice 391 
(Supplementary Fig 7e). Decreased Cidec/Fsp27β gene expression in females was 392 
translated into lower amounts of CIDEC/FSP27 protein in lipid droplets and 393 
microsomes (Supplementary Fig 7f and g). Overall, these findings are suggestive of an 394 
inverse association between Cidec/Fsp27β and Pgc1a expressions as a general response, 395 
independent of absence of APOE. These mRNA changes are reflected in CIDEC/FSP27 396 
protein present in lipid droplets from female livers. 397 
According to this association, it was hypothesized that Pgc1a would reduce the 398 
transcriptional activity of a reporter gene under the control of CIDEC promoter. This 399 
was the case, as shown in Supplemental Fig 5b.  The opposite  hypothesis  would be 400 
that sex-differences in hepatic Cidec/Fsp27 would be abolished in the absence of 401 
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Pgc1a. To test this, Pgc1a- deficient mice from both sexes were fed WD. In this model, 402 
female mice increased hepatic fat area, total cholesterol and TG contents (Fig 6a, b, c). 403 
As shown in Fig 6d, no differences were observed in hepatic Cidec/Fsp27β expression 404 
between sexes when using homozygous Pgc1a-deficient mice. However, the sex 405 
differences at the CIDEC protein levels in lipid droplets and microsomes remained in 406 
absence of PGC1a (Fig 6e and f). These results suggest that absence of PGC1A 407 
abolishes the sex-induced  mRNA changes of hepatic Fsp27β expression in response to 408 
WD, being the transcription factor a transcriptional repressor. However, the sex-induced 409 







The present work explores the putative hepatic Cidec/Fsp27β transcriptional 415 
changes induced by dietary components and sex. Using Apoe-deficient mouse as a 416 
model of hepatic steatosis, dietary cholesterol increased hepatic Cidec/Fsp27β, which 417 
was repressed when combined with saturated fat. The latter was not influenced by 418 
dietary minor components such as oleanolic acid or squalene administered at 419 
pharmacological doses. Moreover, our study revealed a previously unnoticed sex 420 
regulation dependent on the prevailing diet, being the female sex a negative regulator. 421 
An effect observed in two models of genetic hepatic steatosis (Apoe- and Ldlr-deficient 422 
mice) and reflected in CIDEC/FSP27 content of lipid droplets. Using ovariectomized 423 
females, it was shown that ovarian hormones are crucial for the observed decrease in 424 
Cidec/Fsp27β expression noted in Apoe-deficient mice. This effect was also observed in 425 
Wistar female rats. An increased expression of Pgc1a inversely associated with that of 426 
Cidec/Fsp27 and the lack of such effect after ovariectomy in Apoe-deficient mice allow 427 
us to infer that ovarian hormones are executing their action through Pgc1a. This was 428 
confirmed in mice lacking Pgc1a where the sex differences on hepatic Cidec/Fsp27β 429 
were erased providing further in vivo support for this role. However, the sex differences 430 
at the CIDEC/FSP27 content of lipid droplets and microsomes are independent of 431 
PGC1a. 432 
As shown in Supplemental Figure 8, four set of primers were used to study 433 
hepatic Cidec/Fsp27 m RNA expression in mice. With the exception of primers, named 434 
α, corresponding to exon 1, which showed no expression in the liver (data not shown), 435 
the remaining three sets gave concordant results in all experimental conditions. None of 436 
the selected primers amplified the truncated form. Thus, the observed changes 437 
corresponded to Fsp27β, a recently described isoform of the protein regulated by 438 
CREBH (64). 439 
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The present work has explored the influence of two main components of 440 
Western diet, cholesterol and saturated fat. Using the first dietary component, an 441 
increase in the Cidec/Fsp27β expression was noted. Using information from ENCODE, 442 
it was observed that both SREBP1 and 2 bind to this gene (6). Recently, the 443 
involvement of SREBP-1c has been proved (7). Surprisingly, the combination of 444 
cholesterol and saturated diet decreased hepatic Cidec/Fsp27β expression. In this 445 
regard, variable effects of high fat diets have been described depending on the length of 446 
fat administration (36). While a short-term administration (3 weeks) increased the 447 
expression, a long-term administration of 12 weeks had the opposite effect. In this 448 
sense, our study lasted 11 weeks and would be in agreement with the latter finding. 449 
Similar results were observed in Apoe-deficient mouse males receiving an olive oil-450 
enriched diet (15). Likewise, a decreased expression was found in a postprandial 451 
regimen after a virgin olive oil bolus in male Wistar rats and this decrease was inversely 452 
associated with hepatic triglyceride and cholesterol contents (32). In the latter case, the 453 
hepatic mRNA changes occurred just 4 hours after fat intake. In fasting rats, a rapid 454 
increase was equally observed four hours after its start (59). Elevations of Cidec/Fsp27 455 
mRNA expression by high fat diets required additional dietary deficiencies such those 456 
of methionine and choline (Table 2) or under certain metabolic derangements such as 457 
those posed by Db mice, PPAR-alpha-deficient mice (Table 2). In a previous study, 458 
using Apoe-deficient mice with C57BL/6JxOla129 genetic background and fed Western 459 
diets with different conjugated linoleic acid (CLA) isomers, we observed high hepatic 460 
Cidec/Fsp27 mRNA expression in those mice receiving the trans-10,cis-12 CLA isomer 461 
and the levels were associated with the hepatic surface occupied by lipid droplets. In 462 
contrast, when the cis-9, trans-11 CLA isomer was provided resulted in decreased 463 
Cidec/Fsp27 mRNA expression (15). Overall, regimen of administration and nutritional 464 
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components are critical modulators of hepatic Cidec/Fsp27 expression and this mRNA 465 
undergoes a rapid metabolic variation in few hours. 466 
In the present study, the intake of oleanolic acid, a pentacyclic triterpene, and 467 
squalene, a lineal triterpene, had no effect on Cidec/Fsp27β expression despite the 468 
changes induced in lipid droplet area (10). Similar finding was reported by the 469 
administration of a dietary supplement of Boswellia serrata, an extract rich in particular 470 
derivatives of boswellic acid, also a pentacyclic triterpene-based compound (20). As 471 
triterpenes tend to accumulate in the liver altering distribution of triglycerides in lipid 472 
droplets (30, 31), it could be hypothesized that those lipid droplets would not need 473 
changes in Cidec/Fsp27β expression or these are not executed at the mRNA level. 474 
In a previous study, we observed that hepatic Cidec/Fsp27 gene expression was 475 
significantly associated with hepatic surface occupied by lipid droplets in Apoe-476 
deficient mice fed different conjugated linoleic acid isomers, in Cbs-deficient mice and 477 
in olive oil-fed Apoe-deficient mice (15). This was not the case in the present study. 478 
Notably, Cidec/Fsp27β expression was associated with hepatic triglyceride (Figures 3 479 
and 4) or cholesterol contents (Figures 1 and 2).  The genetic background and the diet 480 
composition are main differences between the previous and the current study. The 481 
former one used Ola129xC57BL/6J mixed genetic background mice while the present 482 
study has been carried out using C57BL/6J mice. Due to both strains do have important 483 
differences in hepatic fat content (55), the experimental setting may have influenced the 484 
outcome. The second aspect is the use of AIN-93 purified diet (48) in the present study 485 
compared to commercial ones in the previous one. This choice was forced by the high 486 
variability noted in our lab among control mice for years in atherosclerotic lesions when 487 
using commercial chows and the failure of obtaining the same batch throughout years. 488 
Indeed, source of protein has also been shown to induce changes in Cidec/Fsp27 489 
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expression (61, 65). By and large, dietary components are an important source of 490 
variation (50), and our current study, in well-defined conditions of mouse strains and 491 
purified diets,  adds further evidence supporting this contention.  492 
 A striking result observed in this work was the decreased hepatic Cidec/Fsp27β 493 
expression in female mice consuming WD in Apoe- and in Ldlr-deficient mice. As 494 
consequence of this decrease, the amount of CIDEC/FSP27 protein in lipid droplets was 495 
decreased in females. This fact points to a sex-difference in hepatic regulation of lipid 496 
droplet enlargement considering the role of CIDEC/FSP27 in this process.  An effect 497 
that was abolished when ovariectomy was performed in Apoe-deficient mice and Wistar 498 
rats. Interestingly, female mice lacking steroid receptor coactivator-2 showed increased 499 
hepatic expression of this gene (Table 2). Steroid receptor coactivator-2 promotes the 500 
transcriptional activation of estrogen receptor in some tissues (62). These results are 501 
indicating a negative regulation of the gene by the influence of female hormones. This 502 
could be executed through Pgc1a as the significant inverse association noted between 503 
Pgc1a and Cidec/Fsp27β suggests. Further evidences to this suggestion come from the 504 
binding of PGC1a to this gene as evidenced by ChIP assays reported by the ENCODE 505 
consortium (6). Indeed, estradiol action has been found to be modulated by Pgc1a (4) 506 
and Pgc1a decreased CIDEC promoter activity. When we carried out ovariectomy, the 507 
decrease in Cidec/Fsp27β expression was lost. Deficiency of Pgc1a as the case of the 508 
experiment carried out in Pgc1a-deficient mice is also supporting the role of Pgc1a in 509 
the in vivo sex differences but only at the mRNA levels. This would be in line with a 510 
Pgc1a- independent control of downstream processes thereby Cidec/Fsp27β mRNA is 511 
translated into FSP27β protein either at pre- or posttranslational stages. At least in 512 
adipocytes, FSP27 protein levels are controlled by the catabolic intervention of 513 
proteasomal ubiquitin-dependent proteins. In fact, isoproterenol increases FSP27 levels 514 
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through a delayed degradation rate mediated by decreased ubiquitination (47), while 515 
AMPK activation promoted its degradation (68). Whether or not such mechanisms exist 516 
for FSP27β in the liver are interesting aspects to carry out future experiments. 517 
In conclusion, the present report evidences two axes of hepatic Cidec/Fsp27β 518 
regulation defined by diet and sex. Regarding the first one, cholesterol and the nature of 519 
fatty acids are a key component. On the other hand, the fact that the female decrease in 520 
hepatic gene expression was not observed in ovariectomized mice strongly suggests that 521 
ovarian hormones are involved in the control of hepatic Cidec/Fsp27β  mRNA 522 
expression and this is modulated by Pgc1a. However, the sex-differences at the 523 
CIDEC/FSP27 protein levels observed in lipid droplets and microsomes are 524 
independent of PGC1a. 525 
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Table 1. Summary of experimental conditions 786 
Experiment Genetic 
background 




1 C57BL/6J x 
OLA 129 
Commercial chow (B 
& K Universal Ltd, 
Humberside, UK)  
w/wo 0.1% 
cholesterol for 10 
weeks (1) 




2 C57BL/6J Purified chow and 
Western diets for 11 
weeks 




3 C57BL/6J Purified Western 
w/wo 0.01% 
oleanolic acid (OA) 
(Extrasynthese, 
Genay, France) for 
11 weeks (10) 
Males Western (n=8) 
 
Western + OA 
(n=9) 
Oleanolic acid 
4 C57BL/6J Purified Western 
w/wo 1% squalene 
(Sigma, Madrid, 
Spain) for 10 weeks 
(14) 




5 C57BL/6J Purified chow for 11 
weeks  
Both sexes Males (n=13) 
Females (n=13) 
Sex in chow diet 
6 C57BL/6J Purified Western for 
11 weeks 
 
Both sexes Males (n=9) 
Females (n=10) 
Sex in Western diet 



































Purified Western for 
11 weeks 
 
Both sexes Males (n=17) 
Females (n=18) 






C57BL/6J Purified Western for 
11 weeks 
 
Both sexes Males (n=8) 
Females (n=8) 
Sex in Western diet 













a single injection 
of 1250 µg of  
testosterone 
propionate on 







w/wo, with or without 787 
  788 
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Table 2. Changes in hepatic Cidec/Fsp27 expression according to Genome Expressed 789 
Omnibus data bank and Array express.  790 
Experimental condition Type of change Signal log2 
ratio 
Accession number 
Caspase 1 deficient mice Increased 0.3 GDS4922 
Glycerol kinase knockout Increased 1.9 GDS1555 
NADH-cytochrome P450 
reductase deletion effect 
on liver 
Increased 1.3 GDS1093 
Stearoyl-CoA desaturase 
1-deficient mutants on a 
very low-fat, high-
carbohydrate diet 




Increased 0.8 GDS4785 
Thioredoxin reductase 1-
null liver 
Increased 1.1 GDS4928 
Fasting Increased 0.5 GDS4918 
Fasting and LPS in male 
BL6/SV129 mice 
Increased 5.5 GDS4546 
Alcoholic hepatitis Increased 0.7 GDS4389 
Sebacic acid 
supplemented diet effect 
on db/db liver 
Increased 0.7 GDS3807 
Ketogenic diet effect on 
the liver 
Increased 5.7 GDS2738 
High-fat high-calorie diet 
effect on liver 
Increased 1.3 GDS2413 
Liver response to a high 
fat diet deficient in 
methionine and choline 
Increased 5.3 GDS4883 
Liver response to a high 
fat diet: time course 
Increased 12 h 2.4 GDS4783 
Western diet induced 
changes in liver 
Increased 4.9 GDS279 
Perfluorooctanoic acid 
effect on livers lacking 
PPAR-alpha 
Increased 7.1 GDS3407 
Peroxisome proliferator-
activated receptor 






on liver cell 
Female receiving 
dexamethasone Increased 1.7 GDS5036 
Hepatocyte nuclear factor 
4 alpha depletion on 
hepatocellular carcinoma 
cell line 




effect on the liver 
Decreased -1.3 GDS3197 
RORα-deficient staggerer 
mice fed high fat diet 
Decreased -5.7 GSE23736 
SIRT3 deficient liver 
response to a high fat diet 
Decreased -0.1 GDS4817 
GPR120-deficient liver 
response to a high fat diet 
Decreased -1.3 GDS4830 
TAK1/TR4-deficient 
mice 
Decreased -18 GSE21903 
Conditional GBA1 
deletion model of Type 1 
Gaucher disease 
Decreased -1.4 GDS4162 
Atherogenic diet effect 





type 1 diabetes 
Decreased -0.3 GDS4845 
Adrenalectomized liver at 
light and dark periods of 
the circadian cycle 
Variable Dark 1.0 
Light -1.4 
GDS1870 
Sex specific transcription 
in somatic and 
reproductive tissues 
Decreased -0.6 GDS565 
http://www.ncbi.nlm.nih.gov/gds/ 791 
https://www.ebi.ac.uk/arrayexpress/.   792 




Fig. 1. Effect of dietary cholesterol on hepatic steatosis and Cidec/Fsp27β 795 
expression in male Apoe-deficient mice. Representative liver micrographs at x600 796 
magnification from Apoe-deficient mice consuming the chow (a) and cholesterol-797 
enriched (b) diets. Morphometric evaluation of surface of liver section occupied by fat, 798 
total cholesterol and triglyceride contents (c). Hepatic Cidec/Fsp27β expressions 799 
determined by RT-qPCR normalized to Cyclophilin B (d). Data are medians and 10-90 800 
percentile range for control (n=7) and cholesterol (n=7) groups. Statistical analyses 801 
were done according to Mann-Whitney’s U test. a, P< 0.05 vs control. Association 802 
between hepatic cholesterol content and Cidec/Fsp27β expression (e). Open squares 803 
correspond to control and striped squares to cholesterol-fed mice. Spearman’s 804 
correlation is shown. 805 
 806 
 807 




Fig. 2. Effect of Western diet on hepatic steatosis and Cidec/Fsp27β expression in 810 
male Apoe-deficient mice. Representative liver micrographs at x600 magnification 811 
from Apoe-deficient mice consuming the chow (a) and Western (b) diets. Morphometric 812 
evaluation of surface of hepatocyte occupied by fat and hepatic total cholesterol and 813 
triglyceride contents (c). Analysis of hepatic Cidec/Fsp27β expression determined by 814 
RT-qPCR normalized to Cyclophilin B (d). Data are medians and 10-90 percentile range 815 
for chow (n=13) and Western (n=9) groups. Statistical analyses were done according to 816 
Mann-Whitney’s U test. a, P< 0.05 vs chow. Association between hepatic cholesterol 817 
content and Cidec/Fsp27β expression (e). Spearman’s correlation is shown. Open 818 
squares correspond to control and striped squares to Western-fed mice. 819 




Fig. 3. Effect of sex on hepatic steatosis, Cidec/Fsp27β expression and 822 
CIDEC/FSP27 content in lipid droplets and microsomes in Apoe-deficient mice fed 823 
on a Western diet. Representative liver micrographs at x600 magnification from male 824 
(a) and female (b) Apoe-deficient mice consuming Western diets. Morphometric 825 
evaluation of surface of hepatocyte occupied by fat and hepatic total cholesterol and 826 
triglyceride contents (c). Analysis of hepatic Cidec/Fsp27β expression was determined 827 
by RT-qPCR normalized to Cyclophilin B (d). Data are medians and 10-90 percentile 828 
range for male (n=9) and female (n=10) groups. Relationship between hepatic 829 
triglyceride content and Cidec/Fsp27β gene expression (e). Open squares correspond to 830 
males and striped squares to females. Correlations were calculated according to 831 
Spearman’s test. FSP27 protein levels normalized to HSC70 in lipid droplets (f) and 832 
microsomes (g), inserts show representative Western blots. Statistical analyses were 833 
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Fig. 4. Effect of ovariectomy on hepatic steatosis, Cidec/Fsp27β expression and 841 
CIDEC/FSP27 content in lipid droplets and microsomes in female Apoe-deficient 842 
mice fed on a Western diet. Representative liver micrographs at x600 magnification 843 
from mock (a) and surgically castrated (b) female Apoe-deficient mice consuming 844 
Western diets. Morphometric evaluation of surface of hepatocyte occupied by fat and 845 
hepatic total cholesterol and triglyceride contents (c). Analysis of hepatic Cidec/Fsp27β 846 
expression determined by RT-qPCR normalized to Cyclophilin B (d). Data are medians 847 
and 10-90 percentile range for control (n=9) and castrated (n=9) groups. Relationship 848 
between hepatic triglyceride content and Cidec/Fsp27 gene expression (e). Open 849 
squares correspond to control and striped squares to ovariectomized females. 850 
Correlations were calculated according to Spearman’s test. FSP27 protein levels 851 
normalized to HSC70 in lipid droplets (f) and microsomes (g), inserts show 852 
representative Western blots. Statistical analyses were done according to Mann-853 
Whitney’s U test. a, P< 0.05 vs control.  854 
 855 
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Fig. 5. Effect of sex and castration on hepatic Ppargc1a/Pgc1a expression in Apoe-857 
deficient mice fed on a Western diet. Influence of sex on hepatic Pgc1a expression in 858 
Apoe-deficient mice (a).  Relationship between Cidec/Fsp27β and Pgc1a gene 859 
expression levels (b). Open squares correspond to males and striped squares to females. 860 
Correlations were calculated according to Spearman’s test. Effect of orchiectomy on 861 
hepatic Pgc1a expression in male Apoe-deficient mice (c). Effect of ovariectomy on 862 
Pgc1a expression in female Apoe-deficient mice (d). Analysis of hepatic Pgc1a 863 
expression was determined by RT-qPCR normalized to Cyclophilin B. Data are medians 864 
and 10-90 percentile range for each group. Statistical analyses were done according to 865 








Fig. 6. Effect of sex on hepatic steatosis, Cidec/Fsp27β expression and 872 
CIDEC/FSP27 content in lipid droplets and microsomes in Pgc1a-deficient mice 873 
fed on a Western diet. Representative liver micrographs at x400 magnification from 874 
male (a) and female (b) Pgc1a-deficient mice consuming Western diets. Morphometric 875 
evaluation of surface of hepatocytes occupied by fat and hepatic total cholesterol and 876 
triglyceride contents (c). Analysis of hepatic Cidec/Fsp27β expression was determined 877 
by RT-qPCR normalized to Cyclophilin B (d). Data are medians and 10-90 percentile 878 
range for male (n=8) and female (n=8) groups. FSP27 protein levels normalized to 879 
HSC70 in lipid droplets (e) and microsomes (f), inserts show representative Western 880 
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